Predictors of lymphovascular invasion in estrogen receptor positive/Her-2 negative breast cancer patients treated with neoadjuvant chemotherapy

Cavdar, E; Iriagac, Y

Cavdar, E (通讯作者),Tekirdag Namik Kemal Univ, Dept Med Oncol, Fac Med, Tekirdag, Turkey.

TURKISH JOURNAL OF MEDICAL SCIENCES, 2022; 52 (4): 1111

Abstract

Background/aim: Lymphovascular invasion (LVI) is considered a high-risk factor for recurrence in early-stage breast cancer, hence examination of LVI i......

Full Text Link